| Name | Title | Contact Details |
|---|
innocent started with a simple mission: to make drinks that make it easy to do yourself some good. In 1999 we concocted a few smoothies in our kitchen and tested them on people at a music festival; today were blending every type of fruit & veg under the sun and selling drinks right across Europe in over 30 different countries. Our range has got bigger along with us, and we now sell juice, kids drinks, coconut water and bubbles (a healthy drink in a can) with loads more innovation to come. We have great ambitions: to show the world that you can build a successful business that cares about more than just profit, and to leave things better than we find them. Were proud to call ourselves Europes favourite little healthy drinks company, but were still growing. And that means we need more brilliant people who share our ambition, to join in with the next, most exciting, part of our story.
John R Orlando Funeral Home is a Erie, PA-based company in the Business Services sector.
ANNAS is a Colorado Springs, CO-based company in the Business Services sector.
Dawson Oil Co. is a Rushville, IN-based company in the Business Services sector.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.